BEHIND THE DEAL: Why Medtronic And Qualcomm Are Teaming Up On Diabetes
This article was originally published in Clinica
Executive Summary
Diabetes might be Medtronic’s smallest business division in terms of revenue but its growth rates are far from stunted, having recorded the top-line increases of 6% for both the fourth fiscal quarter and full fiscal year 2016.